Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey.
Corrigendum.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
An Occult Malignancy Behind a Demyelinating Disease: POEMS Syndrome.
Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.
Overview of quantitative susceptibility mapping.
The Impact of the Nurses' Health Study on Population Health: Prevention, Translation, and Control.
Do coping strategies mediate the association between Type D personality and quality of life among people with multiple sclerosis?
Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-YES.
Dynamic Modulation of Myelination in Response to Visual Stimuli Alters Optic Nerve Conduction Velocity.
Anxiety in Multiple Sclerosis: psychometric properties of the State-Trait Anxiety Inventory.
Engineering tolerance using biomaterials to target and control antigen presenting cells.
Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline.
Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine.
Neurodegeneration in multiple sclerosis and neuromyelitis optica.
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.
Receipt of recommended services among patients with selected disabling conditions and diabetes.
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study. A reply.
A mouse model for testing remyelinating therapies.
Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
The effectiveness of the Permission, Limited Information, Specific suggestions, Intensive Therapy (PLISSIT) model based sexual counseling on the sexual function of women with Multiple Sclerosis who are sexually active.

Pages